Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis - Poll - MDSpire

Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis

  • By

  • Asad Omarion

  • Yaman Ayasa

  • Zainab Omarion

  • Batoul Jayouse

  • Hazem Ayesh

  • July 3, 2026

  • 0 min

Share

Original Source(s)

Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis

  • by Asad Omarion, Yaman Ayasa, Zainab Omarion, Batoul Jayouse, Hazem Ayesh

  • July 3, 2026

Related Content

Supreme Court extends mifepristone deadline

Orchestrating the gut microbiota–mitochondrial–immune axis in gynecological diseases: mechanisms and dual-targeting therapeutic strategies

Thyroid autoimmunity does not delineate a cardiometabolic or androgenic phenotype in women with polycystic ovary syndrome: a pre-specified cross-sectional analysis